Marianne P. Allen

Array ( [id] => 13661305 [patent_doc_number] => 10160804 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-12-25 [patent_title] => Antagonists of IL-6 to prevent or treat cachexia, weakness, fatigue, and/or fever [patent_app_type] => utility [patent_app_number] => 15/380203 [patent_app_country] => US [patent_app_date] => 2016-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 39 [patent_no_of_words] => 85921 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15380203 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11527187 [patent_doc_number] => 20170087164 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-03-30 [patent_title] => 'METHOD AND COMPOSITION FOR ENHANCEMENT OF MALE ERECTILE FUNCTION' [patent_app_type] => utility [patent_app_number] => 15/375788 [patent_app_country] => US [patent_app_date] => 2016-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6878 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15375788 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16648774 [patent_doc_number] => 10925928 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-02-23 [patent_title] => Method for treating chemotherapy-induced male infertility [patent_app_type] => utility [patent_app_number] => 15/367383 [patent_app_country] => US [patent_app_date] => 2016-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 9209 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15367383 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12001830 [patent_doc_number] => 20170305985 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-10-26 [patent_title] => 'Hepatocyte Growth Factor Fragments that Function as Potent Met Receptor Agonists and Antagonists' [patent_app_type] => utility [patent_app_number] => 15/365514 [patent_app_country] => US [patent_app_date] => 2016-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 27036 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15365514 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13916703 [patent_doc_number] => 10202459 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-02-12 [patent_title] => Methods of inhibiting pathological angiogenesis with doppel-targeting molecules [patent_app_type] => utility [patent_app_number] => 15/363103 [patent_app_country] => US [patent_app_date] => 2016-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 80 [patent_no_of_words] => 16170 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15363103 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11492647 [patent_doc_number] => 20170066832 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-03-09 [patent_title] => 'COMPOSITIONS AND METHODS FOR BLOOD-BRAIN BARRIER DELIVERY OF IGG-DECOY RECEPTOR FUSION PROTEINS' [patent_app_type] => utility [patent_app_number] => 15/357894 [patent_app_country] => US [patent_app_date] => 2016-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 24859 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15357894 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13659135 [patent_doc_number] => 10159711 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-12-25 [patent_title] => Methods for treating metabolic disorders using FGF [patent_app_type] => utility [patent_app_number] => 15/351104 [patent_app_country] => US [patent_app_date] => 2016-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 59 [patent_no_of_words] => 14879 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15351104 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14718217 [patent_doc_number] => 20190250172 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-08-15 [patent_title] => PROGNOSIS OF ADVERSE OUTCOMES BY DETERMINATION OF MIDKINE LEVELS AFTER CARDIOVASCULAR STRESS [patent_app_type] => utility [patent_app_number] => 15/775753 [patent_app_country] => US [patent_app_date] => 2016-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15581 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15775753 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15267411 [patent_doc_number] => 20190382439 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-12-19 [patent_title] => METHOD FOR EXTENDING HALF-LIFE OF A PROTEIN [patent_app_type] => utility [patent_app_number] => 15/776680 [patent_app_country] => US [patent_app_date] => 2016-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24050 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -67 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15776680 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11442032 [patent_doc_number] => 20170043054 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-02-16 [patent_title] => 'PREPARATIONS CONTAINING HEPATOCYTE GROWTH FACTOR AND HYALURONIC ACID, AND METHODS OF MAKING AND USING SAME' [patent_app_type] => utility [patent_app_number] => 15/337427 [patent_app_country] => US [patent_app_date] => 2016-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4827 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15337427 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12367326 [patent_doc_number] => 09957310 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-05-01 [patent_title] => Fibroblast growth factor mutants having improved functional half-life and methods of their use [patent_app_type] => utility [patent_app_number] => 15/295804 [patent_app_country] => US [patent_app_date] => 2016-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 44 [patent_no_of_words] => 30613 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15295804 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12997561 [patent_doc_number] => 10022426 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-07-17 [patent_title] => Fibroblast growth factor mutants having improved functional half-life and methods of their use [patent_app_type] => utility [patent_app_number] => 15/295774 [patent_app_country] => US [patent_app_date] => 2016-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 44 [patent_no_of_words] => 30607 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15295774 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12509265 [patent_doc_number] => 10000540 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-06-19 [patent_title] => Fibroblast growth factor mutants having improved functional half-life and methods of their use [patent_app_type] => utility [patent_app_number] => 15/295833 [patent_app_country] => US [patent_app_date] => 2016-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 44 [patent_no_of_words] => 30608 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15295833 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11542652 [patent_doc_number] => 20170096478 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-04-06 [patent_title] => 'THERAPEUTIC AGENT FOR INFLAMMATORY DISEASE' [patent_app_type] => utility [patent_app_number] => 15/292450 [patent_app_country] => US [patent_app_date] => 2016-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 10104 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15292450 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12254218 [patent_doc_number] => 09926355 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-03-27 [patent_title] => 'Chimeric fibroblast growth factor 21 proteins and methods of use' [patent_app_type] => utility [patent_app_number] => 15/289447 [patent_app_country] => US [patent_app_date] => 2016-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 50724 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15289447 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12254219 [patent_doc_number] => 09926356 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-03-27 [patent_title] => 'Chimeric fibroblast growth factor 19 proteins and methods of use' [patent_app_type] => utility [patent_app_number] => 15/289544 [patent_app_country] => US [patent_app_date] => 2016-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 50963 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15289544 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11568638 [patent_doc_number] => 20170107280 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-04-20 [patent_title] => 'ANTIBODIES TO HGF AND COMPOSITIONS CONTAINING' [patent_app_type] => utility [patent_app_number] => 15/276868 [patent_app_country] => US [patent_app_date] => 2016-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 99 [patent_figures_cnt] => 99 [patent_no_of_words] => 112205 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15276868 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11543529 [patent_doc_number] => 20170097354 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-04-06 [patent_title] => 'Quantifying Met Protein for Cancer Treatment' [patent_app_type] => utility [patent_app_number] => 15/276686 [patent_app_country] => US [patent_app_date] => 2016-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4571 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15276686 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11381623 [patent_doc_number] => 20170007680 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-01-12 [patent_title] => 'Lysosomal Targeting Peptides and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 15/274115 [patent_app_country] => US [patent_app_date] => 2016-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 17643 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15274115 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11364087 [patent_doc_number] => 20170002068 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-01-05 [patent_title] => 'ANTI AMPHIREGULIN ANTIBODIES, COMPOSITIONS COMPRISING SAME AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 15/271515 [patent_app_country] => US [patent_app_date] => 2016-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 25551 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15271515 [rel_patent_id] =>[rel_patent_doc_number] =>)